Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes...

Frontiers in Oncology 2019 / 4 Vol. 9

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells

Cui, Qingbin, Cai, Chao-Yun, Gao, Hai-Ling, Ren, Liang, Ji, Ning, Gupta, Pranav, Yang, Yuqi, Shukla, Suneet, Ambudkar, Suresh V., Yang, Dong-Hua, Chen, Zhe-Sheng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2019.00313
Date:
April, 2019
File:
PDF, 3.79 MB
english, 2019
Conversion to is in progress
Conversion to is failed